Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity

@article{Raffa2005EtoperidoneTA,
  title={Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity},
  author={Robert B Raffa and Richard P. Shank and Jeffry L. Vaught},
  journal={Psychopharmacology},
  year={2005},
  volume={108},
  pages={320-326}
}
The Ki values for etoperidone, trazodone and MCPP (m-chlorophenylpiperazine dihydrochloride) at 5-HT1A sites (using rat cerebral cortical synaptosomes and [3H]8-OH-DPAT) were determined to be 20.2, 23.6 and 18.9 nM, respectively. In an effort to elucidate the functional nature of the interaction at 5-HT1A sites in vivo, the ability of each compound to elicit reciprocal forepaw treading (RFT) or to block the RFT induced by 8-OH-DPAT in reserpinized rats was tested. Specifically, 8-OH-DPAT (1.0… Expand
Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding
TLDR
The agonist properties of trazodone and its active metabolite, m-chlorophenylpiperazine (m-CPP), at 5-HT1A receptors are elucidated by means of the guanosine-5′-O-(3-[ 35S]thio)-triphosphate ([35S]GTPγS) binding assay. Expand
Daily administration ofm-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects
TLDR
Psychological and physical symptoms of anxiety, temperature, pupil size, diastolic blood pressure, and plasma ACTH, cortisol, and prolactin concentrations were increased by the first administration ofm-CPP compared to placebo, and all of these responses were attenuated onm- CPP days 2 and 3. Expand
Behavioural and Neurochemical Consequences of MDMA Self-Administration in Rats
Rationale: Over the past few decades, MDMA has been shown to produce persistent detrimental effects. Animal models have been developed to investigate the effects of self-administered drugs on brainExpand
Effects of ipsapirone in healthy subjects: a dose-response study
TLDR
IPS at 20 mg PO appears a useful probe to test 5HT1a function when temperature and cortisol are used as response variables and overall it had no significant effect on these parameters. Expand
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
TLDR
The effect fingerprints highlight the main modes of action for the different NPS studied, including inhibition and/or reversal of monoamine reuptake transporters (cathinones and non‐hallucinogenic phenethylamines), activation of 5‐HT2receptors, activation of cannabinoid receptors (cannabinoids) and inhibition of NDMA receptors (arylcyclohexylamines). Expand
Mechanism of Action of Trazodone: a Multifunctional Drug
TLDR
Although trazodone has traditionally been used as a low dose hypnotic, a new controlled release formulation that has the potential to improve the tolerability of high doses may provide an opportunity to revisit this multifunctional drug as an antidepressant as well. Expand
[Personalized medicine with extended-release trazodone and/or once-a-day trazodone: from research trials to clinical practice].
TLDR
The different formulations of trazodone allow a personalization of the treatment, which may be targeted to the specific needs of each patient, as well as identifying the characteristics of patients that may benefit from the use of one of the formulations. Expand
[Multimodal serotonergic antidepressants].
  • D. S. Danilov
  • Medicine
  • Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
  • 2017
TLDR
The data presented suggest the rationale for unifying all selective serotonergic antidepressants, simultaneously inhibiting the serotonin reuptake and directly interacting with serotonin receptors, in one group of 'multimodal serotonergy antidepressants'. Expand
[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].
TLDR
Trazodone is efficacious for the treatment of a broad array of depressive symptoms and is particularly useful for patients presenting with insomnia as one of the symptoms of depression. Expand
Pharmacological Study on Some New 3-[(1-Methylpyrrol-2-yl)- methyl]-4-Substituted 4,5-Dihydro-1H-1,2,4-triazol-5-ones
TLDR
3-[(1-Methylpyrrol-2-yl)methyl]-4-substituted 4,5-dihydro-1H-1,2,4-triazol-5-ones and the effects of the synthesized compounds of the central nervous system of mice were studied. Expand
...
1
2
...

References

SHOWING 1-10 OF 20 REFERENCES
A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
Since 1-(m-chlorophenyl)piperazine (mCPP) is a metabolite of trazodone (TRZ) and etoperidone (ETO), two atypical antidepressants, a pharmacological study was undertaken to establish the possibleExpand
Trazodone, a central serotonin antagonist and agonist
TLDR
It is indicated that TR has a double effect on the central 5-HT system: at low doses it acts as a5-HT antagonist, whereas at higher ones-as a 5- HT agonist, and the latter effect may be connected with formation of a metabolite, CPP, or a compound chemically related to CPP. Expand
1‐m‐Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole
TLDR
Data suggest that mCPP contributes to, or even accounts for, the antidepressant action of the parent drug trazodone. Expand
The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system
TLDR
The above findings indicate that etoperidone has a biphasic action on the serotonergic transmission, revealing characteristics of the 5-HT antagonist and agonist. Expand
Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent.
TLDR
Trazodone is 220 and 370 times more potent in inhibiting 5-HT than NE and DA uptake, respectively, than chlorimipramine. Expand
The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
TLDR
The residual behavioural effects of 8-OH-DPAT in reserpinised rats may, therefore, reflect the consequences of stimulation of the putative 5-HT1A receptor. Expand
Inhibitory effects of etoperidone on the spontaneous activity of brainstem neurones and their excitatory responses to some putative transmitters.
TLDR
All the excitatory neuronal responses to ACh, 5 HT and NA (interpreted respectively as nicotinic cholinergic, alpha-noradrenergic, 5HT3-serotonergic) were blocked by ET, while the inhibitory responses to 5HT, NA and GABA were not affected. Expand
(—)‐m‐Chlorophenyl‐piperazine, a central 5‐hydroxytryptamine agonist, is a metabolite of trazodone
binding sites, particularly on a brain regional basis, and Fillion, G., Rousselle, J.-C., Fillion, M.-P., Beaudoin, may confirm the existence of separate S-HT receptors. D. M., Goiny, M. R., Deniau.Expand
Pharmacological properties of AF 1161, a new psychotropic drug.
TLDR
AF 1161 possesses a very slight anti-histamine action, a moderate adrenolytic action and a powerful anti-serotonin action, and possible therapeutic use in man of AF 1161 is postulated. Expand
Biochemical Effects of Some New Antidepressants: Putative Mechanisms of Antidepressant Effect
TLDR
It is suggested that the anxiolytic effects of drugs effective in depression are attributable to their ability to diminish transmission in a serotonergic anxiety-punishment system either indirectly or directly by blocking the serotonin receptor. Expand
...
1
2
...